We are live on ! Find out more
MDXH icon

MDxHealth

12 hedge funds and large institutions have $37.5M invested in MDxHealth in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

99% more capital invested

Capital invested by funds: $18.9M → $37.5M (+$18.6M)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

10.13% more ownership

Funds ownership: 25.04%35.17% (+10%)

9% more funds holding

Funds holding: 1112 (+1)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.17%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
3
Increased
5
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

MDXH Hedge Fund Activity: Q4 2023 in Review

12 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in MDxHealth (MDXH) for Q4 2023, worth a combined $37.5M — up 99% from $18.9M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new MDXH positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 1 trimmed.

The largest buyer was MVM Partners, adding an estimated $7.88M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $783K sold.

  • 12 institutional investors held MDxHealth (MDXH) as of Q4 2023, up from 11 in Q3 2023.
  • Funds reported $37.5M of MDxHealth stock for Q4 2023, up 99% quarter-over-quarter.
  • 3 funds opened new MDxHealth positions in Q4 2023 and 2 closed out, a net change of +1 holder.
  • The largest MDxHealth buyer in Q4 2023 was MVM Partners, an estimated $7.88M added.
  • The largest MDxHealth seller in Q4 2023 was Alyeska Investment Group, an estimated $783K sold.

Based on aggregated 13F filings for Q4 2023.